PharmInfoNet

Image from WebPath, courtesy of Edward C. Klatt, MD, University of Utah

DIABETES-EHLB features the dissemination and archive of electronic highlights bulletins from a variety of international diabetes meetings such as the annual American Diabetes Association (ADA) scientific meeting. Between meetings the list is devoted to moderated discussions involing both patients and healthcare professionals interested in the management of diabetes.

Diabetes Information Center

DIABETES-EHLB

Discussion Group and Resource Center

DIABETES-EHLB is owned and moderated by VirSci Corporation.

Description
This discussion group is for health professionals, people with diabetes, and others interested in the understanding and proper management of diabetes. Here we describe the purpose and scope of the group and who would benefit from subscribing.

How to Subscribe
You must subscribe to the list to participate in the discussion. Here are the simple instructions for subscribing.

Discussion Threads
Selected and edited topics from the DIABETES-EHLB archives.

Searchable, Complete Archives


Description

DIABETES-EHLB is an independent mailing list owned and moderated by VirSci Corporation. Certain content or programs distributed through this list may be supported by various professional societies and/or pharmaceutical companies. Such sponsorship is gratefully acknowledged and will be clearly noted where appropriate.

DIABETES-EHLB sometimes features the dissemination of electronic highlights bulletins from a variety of international diabetes meetings such as the annual American Diabetes Association (ADA) scientific meeting.

Between meetings the list is devoted to moderated discussions involing both patients and healthcare professionals interested in the management of diabetes. The volume of email from the list is kept low by encouraging subscribers to carry on lengthy discussions privately.

For more information regarding sponsorship, contact VirSci Corporation

Return to top...


How to Subscribe

Send an E-mail message to LISTSERV@virsci.com with the following in the message body:

SUBSCRIBE DIABETES-EHLB firstname lastname

substitute your own first and last names (as in SUBSCRIBE DIABETES-EHLB Jane Doe). DO NOT INCLUDE ANY OTHER TEXT IN THE BODY OF THE MESSAGE (not even a "signature").

You will receive notification via return email from the listserv.

Return to top...


PharmInfoNet
Last modified on .
© 1999 Mediconsult.com, Limited. All rights reserved. As seen on PharmInfoNet ()